Michael Orsini is a dynamic pharmaceutical professional with over 20 years of experience in drug discovery and clinical development in various therapeutic areas including oncology, metabolic, and cardiovascular diseases. Currently serving as the Director of Clinical Development Project Management at Eisai US, they lead global project management efforts for oncology and neuroscience assets. Previously, Michael held significant roles at notable companies such as Merck and Bristol-Myers Squibb, where they managed key oncology projects and contributed to the development of therapies that reached first-in-human trials. They are a Project Management Professional (PMP)-certified leader, dedicated to integrating scientific expertise with strategic project management to deliver innovative solutions in healthcare. Michael is also pursuing a B.Sc. in Biochemistry at Cornell University.
This person is not in any teams
This person is not in any offices